The Small Molecules Targeting Ubiquitin-Proteasome System for Cancer Therapy

被引：30

作者：

Ao, Nannan ^{[1
]}

Chen, Qianping ^{[1
]}

Liu, Geng ^{[1
]}

机构：

[1] Soochow Univ, Med Coll, Sch Radiat Med & Protect, Collaborat Innovat Ctr Radiol Med Jiangsu Higher, Suzhou 215123, Peoples R China

来源：

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING | 2017年 / 20卷 / 05期

关键词：

Ubiquitin; cancer; small molecule inhibitors; proteasome; E3; ligase; deubiquitinating enzyme; LOW-DOSE DEXAMETHASONE; MULTIPLE-MYELOMA CELLS; IN-VITRO; DEUBIQUITINASE INHIBITION; UBC13-UEV1A INTERACTION; IRREVERSIBLE INHIBITOR; PRECLINICAL MODELS; ANTITUMOR-ACTIVITY; MDM2; INHIBITOR; 26S PROTEASOME;

D O I：

10.2174/1386207320666170710124746

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Background & Aim: The ubiquitin-proteasome system (UPS) is the major pathway for degrading the intracellular proteins. The 2004 Nobel Prize in Chemistry was awarded to Rose, Hershko, and Ciechanover to highlight the fundamental importance of UPS. Method & Results: The alterations in this process have been shown to contribute to the cancer progression. Hence, UPS has become a popular target for developing chemotherapeutics against tumours. The application of bortezomib showed high efficiency in treating haematological malignancies by interfering with UPS activity. Many compounds are being screened and evaluated in recent pharmacological advances, either as single agents or in synergy with other drugs, and more to be revealed. Conclusion: In the present review, we exhibit the crucial ingredients involved in UPS and discuss the current situation of small molecules targeting various components of ubiquitination pathway in cancer treatment.

引用

页码：403 / 413

页数：11

共 50 条

[21] The ubiquitin-proteasome system
Dipankar Nandi
Pankaj Tahiliani
Anujith Kumar
Dilip Chandu
Journal of Biosciences, 2006, 31 : 137 - 155
[22] Targeting Ubiquitin-Proteasome system (UPS) in treating osteoarthritis
Wong, Pooi-Fong
Kamarul, Tunku
EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 989
[23] The ubiquitin-proteasome system
Nandi, D
Tahiliani, P
Kumar, A
Chandu, D
JOURNAL OF BIOSCIENCES, 2006, 31 (01) : 137 - 155
[24] Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system
Tsai, Yien Che
Maditz, Rhyan
Kuo, Chueh-ling
Fishman, Paul S.
Shoemaker, Charles B.
Oyler, George A.
Weissman, Allan M.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (38) : 16554 - 16559
[25] Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapy
Allende-Vega, Nerea
Saville, Mark K.
SEMINARS IN CANCER BIOLOGY, 2010, 20 (01) : 29 - 39
[26] Ubiquitin-proteasome systemThe ubiquitin-proteasome system: past, present and future
W. Hilt
D. H. Wolf
Cellular and Molecular Life Sciences CMLS, 2004, 61 : 1545 - 1545
[27] State of the art: Targeting the ubiquitin-proteasome system for drug discovery
Tsukamoto, S
Yokosawa, H
JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2004, 62 (10) : 968 - 977
[28] New strategies for targeting the ubiquitin-proteasome pathway in cancer.
Deshaies, R
Verma, R
King, R
Fushman, D
Ambroggio, X
Sakamoto, K
Crews, C
CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6272S - 6273S
[29] The ubiquitin-proteasome pathway as a target for breast cancer therapy
Orlowski, RZ
BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S4 - S5
[30] Ubiquitin-proteasome system and proteasome inhibition: New strategies in stroke therapy
Wojcik, C
Di Napoli, M
STROKE, 2004, 35 (06) : 1506 - 1518

← 1 2 3 4 5 →